Literature DB >> 29429831

Predictors of poor outcome in children with steroid sensitive nephrotic syndrome.

Kirtisudha Mishra1, Sandeep Kumar Kanwal2, Sushma Veeranna Sajjan2, Vikram Bhaskar2, Bimbadhar Rath2.   

Abstract

BACKGROUND AND
OBJECTIVE: Nearly 50% of the children with steroid sensitive nephrotic syndrome (SSNS) have a frequently relapsing (FR) or steroid dependent (SD) course, experiencing steroid toxicities and complications of immunosuppression. The study aimed to compare parameters between children with infrequent relapsing (IFR) and FR/SD nephrotic syndrome and to identify the factors associated with a FR/SD course.
METHODS: A retrospective analysis of medical records from 2009 to 2014, of children with SSNS attending the pediatric nephrology clinic in a tertiary care medical college and hospital.
RESULTS: Out of 325 children (226 males) with SSNS, 213 were IFR and 112 were FRNS/SDNS. The median age of onset was 34 (IQR 24-48) months. The median time to the first relapse was 4 (IQR 3-7) months and 6 (IQR 4-12) months in FR/SD and IFR group respectively. Multivariate logistic regression analysis showed "adequate treatment (≥12 weeks) of the first episode" (odds ratio 0.56, 95% CI 0.34-0.91; p value=0.02) and "shorter median time to the first relapse" (odds ratio 1.04, 95% CI=1.01-1.08; p value=0.04) to be independent predictors of FR/SD course. An ROC curve was constructed which showed that time to first relapse <5.5 months was associated with a sensitivity of 69% and specificity of 60% in predicting a FR/SD course.
CONCLUSION: Adequate treatment of the first episode is associated with less chance of an FR/SD course. After treatment of first episode, the first relapse occurring within 5.5 months may predict a frequently relapsing or steroid dependent course.
Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Children; India; Nephrotic syndrome; Niños; Recaídas; Relapses; Síndrome nefrótico

Mesh:

Substances:

Year:  2018        PMID: 29429831     DOI: 10.1016/j.nefro.2017.11.022

Source DB:  PubMed          Journal:  Nefrologia (Engl Ed)        ISSN: 2013-2514


  3 in total

1.  Clinical effect of different prednisone regimens in the treatment of children with primary nephrotic syndrome and risk factors for recurrence.

Authors:  Hai-Yun Geng; Chao-Ying Chen; Juan Tu; Hua-Rong Li; Pei-Wei DU; Hua Xia; Xiao-Ning Yu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

2.  Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.

Authors:  Deepika Kainth; Pankaj Hari; Aditi Sinha; Shivam Pandey; Arvind Bagga
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-21       Impact factor: 8.237

3.  Treatment Outcomes of Pediatric Nephrotic Syndrome Patients Treated in Ayder Comprehensive Specialized and Mekelle General Hospitals, Ethiopia.

Authors:  Yainu Welegerima; Mamo Feyissa; Teshome Nedi
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-05-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.